LVTX(Delisted)
LAVA Therapeutics·NASDAQ
--
--(--)
5.17 / 10
Netural
Analysts (2 neutral) show 100% historical accuracy but no bullish bias. Fund flow (7.49/10) reveals positive inflow ratios (37.8%) despite negative overall trend, suggesting conflicting capital dynamics with neutral analyst outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-05
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of LVTX?
- LVTX holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.17/10 (Netural).
